C12N 2502/137
Blood-borne mesenchymal stem cells
Official title: Blood-borne mesenchymal stem cells, e.g. Msc from umbilical cord blood
C12N2502/137 (Blood-borne mesenchymal stem cells) appears on 23 US grants and 50 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 50
- Assignees
- 39
- Inventors
- 103
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 4 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 5 | 4 |
| 2015 | 2 | 3 |
| 2016 | 0 | 3 |
| 2017 | 1 | 2 |
| 2018 | 2 | 0 |
| 2019 | 2 | 2 |
| 2020 | 2 | 3 |
| 2021 | 0 | 3 |
| 2022 | 0 | 5 |
| 2023 | 3 | 6 |
| 2024 | 1 | 3 |
| 2025 | 0 | 3 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Suppression of diabetes using exosomes from stem cell programmed myeloid cells22 Sep 2026US 12,741,015 B2Creative Medical Technologies, Inc.
- Stem cell and tissue cultures and their products11 Aug 2026US 12,703,855 B2Stem Cell Reserve LP
- Extracellular vesicles (EVs) derived from mesenchymal stromal cells and method for obtaining said EVs12 May 2026US 12,624,343 B2Exo Biologics SA
- Method for producing extracellular vesicles comprising fetus-derived primal immunoglobulin26 Nov 2024US 12,150,962 B2Stemmedicare Co., Ltd.
- Methods and devices for the generation of oocytes with improved oocyte quality for in vitro fertilization procedures using non-invasive cellular transfer26 Dec 2023US 11,851,675 B2The Chinese University of Hong Kong
- Composition for amplifying ability of mesenchymal stem cells to differentiate into adipocytes23 Jul 2026US 2026/0209706 A1Juntendo Educational Foundation
- Method of using factor rich product from umbilical cord mesenchymal stem cells to increase collagen and elastin in human skin17 Jul 2025US 2025/0230404 A1
- Method for enriching muse cells and obtaining exosomes, microvesicles or the secretome therefrom29 May 2025US 2025/0170183 A1JLM ExoGrade, LLC
- Frozen and freeze-dried mitochondria and use thereof13 Feb 2025US 2025/0049856 A1Paean Biotechnology Inc.
- Cell-derived vesicles with increased cellular uptake capacity and method for producing same12 Sep 2024US 2024/0299577 A1Mdimune Inc.
Most cited
By later US patents
- Blood brain barrier device12US 8,900,865 B2The Invention Science Fund I, LLC · 2014
- Choroid plexus device11US 8,053,220 B2The Invention Science Fund I, LLC · 2011
- Composition comprising a culture solution of mesenchymal stem cells for the treatment of neural diseases5US 10,238,692 B2Medipost Co., Ltd. · 2019
- CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using5US 8,772,028 B2Sunnybrook Health Sciences Centre · 2014
- Blood brain barrier device4US 8,114,647 B2The Invention Science Fund I, LLC · 2012